Author(s)

Abel Pérez-Pavón¹, Sigrid Lorena Martínez-Vazquez¹, Jorge Iván Martínez-Pérez¹, Jorda Aleiria Albarrán-Melzer², Juan Antonio Córdova-Hernández², Sergio De Jesús Romero-Tapia², Sergio Quiroz-Gomez², Crystell G. Guzmán-Priego^2*

¹Social Security Institute of the State of Tabasco, Villahermosa, Mexico.
²Cardiometabolism Laboratory, Academic Division of Health Sciences, Juarez Autonomous University of Tabasco, Villahermosa, México.

SARS-CoV-2 infection is a viral disease that causes respiratory infections that can cause multiple complications. Patients with adjacent morbidities have a higher chance of complications and mortality. The National Health and Nutrition Survey (ENSANUT) in 2018 reported that in Mexico, 75.2% of adults aged 20 years and over are overweight and obese, both situations are closely related to the cases reported as severe COVID and even with a higher risk of mortality. The main objective was to evaluate the risk and mortality groups in patients with SARS-CoV-2 from family medicine in the south of México. The study was carried out during the 2020 year, in the Family Medicine Unit No. 43 of Villahermosa, Tabasco, a cross-sectional, retrospective investigation was carried out with an analytical approach, and the sample was obtained using the formula of n for infinite populations that correspond to 215, patients were included who met the selection criteria; 3 groups were integrated: DM2, HAS and obesity. Descriptive statistics andχ² formula were used, using the SPSS version 25 Windows program. The female gender presented the highest number of infections 122 (56.7%) and mortality: 5 (2.32%), obesity comorbidity presented the highest number of infections: 194 (90.2%), HAS: 153 (71.2%), and MD: 44 (20.46%). Complications were observed in 23 (10.69%), distributed in: SIRA: 7 (3.3%), multiple organ failure: 6 (2.8%), heart failure: 6 (2.8%) and pneumonia 4 (1.9%). The observed mortality was 8 (3.72%). The comorbidities of patients with the highest mortality were: SAH: 6 (75%) (χ² = 9.169; df = 1; p = 0.010) and obesity: 6 (75%) (χ² = 9.169; df = 1; p = 0.010). The group with the highest risk for SARS-CoV-2 was patients with overweight/obesity comorbidities. Mortality was 3.7%. The patients who died had at least one or more comorbidities. The main complications were ARIS, heart failure, and multiple organ failure.

Pandemic, COVID-19, SARS-CoV-2, Hypertension, Diabetes, Obesity, Mortality

Pérez-Pavón, A. , Martínez-Vazquez, S. , Martínez-Pérez, J. , Albarrán-Melzer, J. , Córdova-Hernández, J. , Romero-Tapia, S. , Quiroz-Gomez, S. and Guzmán-Priego, C. (2023) Risk Groups and Mortality in Patients with SARS-CoV-2 from Family Medicine Unit No. 43 in Southeastern Mexico. Journal of Biosciences and Medicines, 11, 116-122. doi: 10.4236/jbm.2023.111012.